Alps Advisors Inc Arcutis Biotherapeutics, Inc. Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023
SELL
$10.23 - $17.14 $11,242 - $18,836
-1,099 Reduced 2.66%
40,244 $442,000
Q4 2022

Feb 14, 2023
BUY
$13.96 - $20.4 $119,078 - $174,012
8,530 Added 26.0%
41,343 $611,000
Q3 2022

Nov 14, 2022
BUY
$17.85 - $26.95 $41,304 - $62,362
2,314 Added 7.59%
32,813 $627,000
Q2 2022

Aug 11, 2022
SELL
$16.33 - $22.2 $347,567 - $472,504
-21,284 Reduced 41.1%
30,499 $650,000
Q1 2022

May 16, 2022
SELL
$14.38 - $22.79 $92,319 - $146,311
-6,420 Reduced 11.03%
51,783 $997,000
Q4 2021

Feb 09, 2022
SELL
$14.98 - $25.5 $50,557 - $86,062
-3,375 Reduced 5.48%
58,203 $1.21 Million
Q3 2021

Nov 15, 2021
SELL
$19.28 - $27.1 $87,646 - $123,196
-4,546 Reduced 6.87%
61,578 $1.47 Million
Q2 2021

Aug 11, 2021
SELL
$24.42 - $34.75 $598,045 - $851,027
-24,490 Reduced 27.03%
66,124 $1.81 Million
Q1 2021

May 07, 2021
BUY
$24.47 - $36.98 $528,282 - $798,361
21,589 Added 31.28%
90,614 $2.62 Million
Q4 2020

Feb 03, 2021
BUY
$17.82 - $31.73 $362,298 - $645,102
20,331 Added 41.75%
69,025 $1.94 Million
Q3 2020

Nov 04, 2020
SELL
$23.44 - $32.28 $78,734 - $108,428
-3,359 Reduced 6.45%
48,694 $1.43 Million
Q2 2020

Aug 05, 2020
BUY
$24.48 - $36.56 $1.27 Million - $1.9 Million
52,053 New
52,053 $1.57 Million

Others Institutions Holding ARQT

# of Institutions
197
Shares Held
129M
Call Options Held
738K
Put Options Held
82K
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $557M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email